>
>
>
We help identify and validate biomarkers that improve the accuracy of cancer diagnosis and treatment selection.
Genomic Biomarkers
Next-Gen Sequencing, microarrays, CRISPR-engineered profiling
Applications in NSCLC, pancreatic cancer, head & neck cancers
Proteomic Biomarkers
LC-MS and quantitative proteomics platforms
Plasma signatures, tumor tissue analysis, phospho-protein mapping
Validation with MALDI-TOF
Protein and peptide profiling
Tumor heterogeneity mapping via imaging
High-throughput, reproducible detection methods
Our biomarker platform enables earlier diagnosis, patient stratification, and therapy response prediction.
